Activation of p53 also promotes an anti-tumour immune ... ‘Brightline-1’, comparing BI 907828 with doxorubicin in first-line treatment of patients with advanced dedifferentiated liposarcoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback